Professore Ordinario
MED/18
Direttore UOC Chirurgia dei Trapianti
Policlinico Tor Vergata
Torre 6 – Piano 3 Ovest
Stanza 26
06.20902489
tisone@med.uniroma2.it
Name Giuseppe Tisone
Date of Birth November 7th, 1955
Place of Birth Rome
Nationality Italian
Email tisone@med.uniroma2.it
Telephone +3906 20902498
Fax +3906 20902592
Address U.O.C. Chirurgia dei Trapianti
Fondazione Policlinico Tor Vergata Viale Oxford n. 81- Cap 00133 Roma
Education and training
Graduate: 25th July 1980, “La Sapienza University” of Rome (Italy) 110/110 magna cum laude Degree : Medical Doctor
Post-graduate: 25th July 1985, La Sapienza University” of Rome (Italy) 70/70 magna cum laude. Degree : Surgeon in General Surgery
Post-graduate: 14th November 1990, La Sapienza University” of Rome (Italy) 70/70 magna cum laude. Degree : Surgeon in Vascular Surgery
Senior Lecturer qualified as First Assistant in “Clinica Chirurgica” – Tor Vergata University of Rome from 01/10/1984 to 01/03/2000.
Associated Professor of Surgery – Tor Vergata University of Rome from March 2000.
Director of Transplant Unit – Tor Vergata University of Rome from November 2004
Postgraduate training
1981: Mount Sinai Medical Centre, New York Moffit Hospital, San Francisco
1984 – 1987, 1990, 1991, 1995 : Liver Unit
Queen Elizabeth Hospital, Birmingham, UK
University of Birmingham
Prof. Mc Master
February-March 1987: Addenbrook’s Hospital, Cambridge (GB)
Prof. Sir Roy Calne.
Research activities
· Immunosuppression after liver transplantation, primarily focused on its weaning
· Tolerance after transplantation
· Techniques of organ conservation
· Transplantation
· Biliary acids in liver transplant
· HCV recurrence after Liver transplantation
Operating cases
Performed as First surgeon about 2500 surgical operations (600 liver transplants, many kidney transplants, 600 liver resections, 100 pancreatic resections…) and many laparoscopic operations.
University activity
– Professor of Hepatobiliary Surgery in the Medical School, “Tor Vergata” University of Rome.
– Professor of General Surgery and Orthopaedics and Trauma Surgical Post-graduate Schools, “Tor Vergata” University of Rome.
– In the last years Professor Lecturer in many courses about Transplantation.
– Author and co-author of more than 150 publications on international journals.
Participant in several sponsor international multicenter trials conducted following the ICH-GCP requirements in continuous update.
CURRICULUM VITAE in ITALIANO
Nome Giuseppe Tisone
Data di nascita 7 Novembre 1955
Luogo di nascita Roma
Cittadinanza Italiana
Email tisone@med.uniroma2.it
Recapito telefonico +393356244115
Lingua straniera Ottima conoscenza di inglese scritto e parlato
Professore Associato di Chirurgia Generale dell’ Università di Roma “Tor Vergata” dal Marzo 2000.
Direttore della U.O.C. “Chirurgia dei Trapianti” presso la Fondazione “Policlinico Tor Vergata”, Università degli studi di Roma “Tor Vergata” dal Novembre 2011.
Primario del reparto di “Chirurgia generale I A.S. centro trapianti” dal Novembre 2004 all’ottobre 2010.
Ha conseguito il diploma di specialista in Chirurgia Generale presso la II Scuola di Specializzazione (Dir. Prof. G. Castrini) della Università di Roma “La Sapienza”.
Ha conseguito il diploma di specialista in Chirurgia Vascolare presso la II Scuola di Specializzazione (Dir. Prof. P. Fiorani) della Università di Roma “La Sapienza”.
I settori della ricerca di cui si è occupato, pubblicando una serie di lavori scientifici e partecipando a numerosi congressi internazionali, anche in qualità di relatore, sono: TRAPIANTI d’ORGANO, TOLLERANZA, MODULAZIONE della TERAPIA IMMUNOSOPPRESSIVA, TECNICHE di CONSERVAZIONE degli ORGANI.
E’ titolare d’insegnamento in diversi Corsi di Laurea e Scuole di specializzazione dell’ Università di Roma “Tor Vergata.
Ha eseguito in prima persona oltre 2000 interventi chirurgici tra i quali più di 600 trapianti di fegato e numerosi trapianti di rene, oltre 650 resezioni epatiche e più di 100 resezioni pancreatiche. Esegue inoltre la chirurgia laparoscopica.
Pubblicazioni degli ultimi 5 anni
1. Head and neck and esophageal cancers after liver transplant: results from a multicenter cohort study. Italy, 1997-2010. Piselli P, Burra P, Lauro A, Baccarani U, Ettorre GM, Vizzini GB, Rendina M, Rossi M, Tisone G, Zamboni F, Bortoluzzi I, Pinna AD, Risaliti A, Galatioto L, Vennarecci G, Leo AD, Nudo F, Sforza D, Fantola G, Cimaglia C, Verdirosi D, Virdone S, Serraino D; Italian Transplant Cancer Cohort Study.
2. Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. TruneČka P, Klempnauer J, Bechstein WO, Pirenne J, Friman S, Zhao A, Isoniemi H, Rostaing L, Settmacher U, Mönch C, Brown M, Undre N, Tisone G; on behalf of the DIAMOND† study group. Am J Transplant. 2015 Feb 23. doi: 10.1111/ajt.13182.
3. Improved Survival in Liver Transplant Recipients Receiving Prolonged-Release Tacrolimus in the European Liver Transplant Registry. Adam R, Karam V, Delvart V, Trunečka P, Samuel D, Bechstein WO, Němec P, Tisone G, Klempnauer J, Rossi M, Rummo OO, Dokmak S, Krawczyk M, Pratschke J, Kollmar O, Boudjema K, Colledan M, Ericzon BG, Mantion G, Baccarani U, Neuhaus P, Paul A, Bachellier P, Zamboni F, Hanvesakul R, Muiesan P; all contributing centers (www.eltr.org) and the European Liver Intestine Transplant Association (ELITA). Am J Transplant. 2015 Feb 19.
4. Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis. Manzia TM, Tariciotti L, Angelico R, Toti L, Anselmo A, Tisone G. Int J Surg Case Rep. 2015
5. A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? Ponticelli C, Carmellini M, Tisone G, Sandrini S, Segoloni G, Rigotti P, Colussi G, Stefoni S. Transplant Proc. 2014 Dec;46(10):3375-82
6. One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial. Orlando G, Manzia TM, Sorge R, Iaria G, Angelico R, Sforza D, Toti L, Peloso A, Patel T, Katari R, Zambon JP, Maida A, Salerno MP, Clemente K, Di Cocco P, De Luca L, Tariciotti L, Famulari A, Citterio F, Tisone G, Pisani F, Romagnoli J. Surgery. 2015 Jan;157(1):104-10.
7. Myopericytoma of the liver hilus: a case report. Ferlosio A, Manzia TM, Anemona L, Tisone G, Orlandi A. Turk Patoloji Derg. 2014;30(3):215-9.
8. Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients. Manzia TM, Angelico R, Ciano P, Mugweru J, Owusu K, Sforza D, Toti L, Tisone G. World J Gastroenterol. 2014 Sep 14;20(34):12217-25.
9. Kidney transplant: usefulness of real-time elastography (RTE) in the diagnosis of graft interstitial fibrosis. Orlacchio A, Chegai F, Del Giudice C, Anselmo A, Iaria G, Palmieri G, Di Caprera E, Tosti D, Costanzo E, Tisone G, Simonetti G. Ultrasound Med Biol. 2014 Nov;40(11):2564-72.
10. Relationship between GH/IGF-1 axis, graft recovery, and early survival in patients undergoing liver transplantation. Salso A, Tisone G, Tariciotti L, Lenci I, Manzia TM, Baiocchi L. Biomed Res Int. 2014;2014:240873. doi: 10.1155/2014/240873. Epub 2014 Apr 1.
11. Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. Ponziani FR, Viganò R, Iemmolo RM, Donato MF, Rendina M, Toniutto P, Pasulo L, Morelli MC, Burra P, Miglioresi L, Merli M, Di Paolo D, Fagiuoli S, Gasbarrini A, Pompili M; AISF RECOLT-C Group, Belli L, Gerunda GE, Marino M, Montalti R, Di Benedetto F, De Ruvo N, Rigamonti C, Colombo M, Rossi G, Di Leo A, Lupo L, Memeo V, Bringiotti R, Zappimbulso M, Bitetto D, Vero V, Colpani M, Fornasiere E, Pinna AD, Morelli MC, Bertuzzo V, De Martin E, Senzolo M, Ettorre GM, Visco-Comandini U, Antonucci G, Angelico M, Tisone G, Giannelli V, Giusto M. Dig Liver Dis. 2014 May;46(5):440-5.
12. Deep vein thrombosis as debut of cytomegalovirus infection associated with type II cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: a case report. Sforza D, Iaria G, Tariciotti L, Manuelli M, Anselmo A, Ciano P, Manzia TM, Toti L, Tisone G. Transplant Proc. 2013 Sep;45(7):2782-4.
13. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008. Ettorre GM, Piselli P, Galatioto L, Rendina M, Nudo F, Sforza D, Miglioresi L, Fantola G, Cimaglia C, Vennarecci G, Vizzini GB, Di Leo A, Rossi M, Tisone G, Zamboni F, Santoro R, Agresta A, Puro V, Serraino D. Transplant Proc. 2013 Sep;45(7):2729-32
14. Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature. Framarino-dei-Malatesta M, Derme M, Manzia TM, Iaria G, De Luca L, Fazzolari L, Napoli A, Berloco P, Patel T, Orlando G, Tisone G. Expert Rev Clin Immunol. 2013 Aug;9(8):781-9.
15. Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation. Lai Q, Avolio AW, Graziadei I, Otto G, Rossi M, Tisone G, Goffette P, Vogel W, Pitton MB, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group. Liver Transpl. 2013 Oct;19(10):1108-18.
16.Liver abscess caused by foreign body ingestion. Manzia TM, Sforza D, Biancone L, Tisone G. Dig Liver Dis. 2013 Aug;45(8):699
17. Prospective multi-center clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M, López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Hepatology. 2013 Mar 26.
18. Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER). Schlitt HJ, Jonas S, Ganten TM, Grannas G, Moench C, Rauchfuss F, Obed A, Tisone G, Pinna AD, Gerunda GE, Beckebaum S. Clin Transplant. 2013 Feb 13.
19. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G. Transpl Int. 2013 Mar;26(3):259-66.
20. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study. Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; For the Liver Match Investigators. J Hepatol. 2012 Nov 28.
21. Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. Manzia TM, Angelico R, Toti L, Lai Q, Ciano P, Angelico M, Tisone G. Expert Rev Clin Immunol. 2012 Sep;8(7):635-44.
22. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, Rigotti P, Busnach G, Messa P, Donati D, Schena FP, Maresca MC, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F; Immunosuppression and Cancer Study Group. Eur J Cancer. 2013 Jan;49(2):336-44.
23. Everolimus and enteric-coated mycophenolate sodium ab initio after liver transplantation: midterm results. Manzia TM, Sforza D, Angelico R, Bellini MI, Ciano P, Manuelli M, Toti L, Tisone G. Transplant Proc. 2012 Sep;44(7):1942-5.
24. Leptin attenuates ischemia-reperfusion injury in the rat liver. Carbone M, Campagnolo L, Angelico M, Tisone G, Almerighi C, Telesca C, Lenci I, Moscatelli I, Massoud R, Baiocchi L. Transpl Int. 2012 Dec;25(12):1282-8.
25. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. Lai Q, Avolio AW, Lerut J, Singh G, Chan SC, Berloco PB, Tisone G, Agnes S, Chok KS, Sharr W, Rossi M, Manzia TM, Lo CM. J Hepatol. 2012 Nov;57(5):974-9.
26. Emergency endovascular repair in a patient with abdominal aortic aneurysm with pelvic transplant kidneys: case report. Smedile G, Bellini MI, Iaria G, Castrucci T, De Luca L, Leporelli P, Booth C, Orlando G, Tisone G. Exp Clin Transplant. 2012 Dec;10(6):601-4.
27.Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Banff Working Group on Liver Allograft Pathology. Liver Transpl. 2012 Oct;18(10):1154-70.
28. Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. Giannelli V, Giusto M, Farcomeni A, Ponziani FR, Pompili M, Viganò R, Iemmolo RM, Donato MF, Rendina M, Toniutto P, Pasulo L, Morelli MC, De Martin E, Miglioresi L, Di Paolo D, Fagiuoli S, Merli M; AISF RECOLT-C group study. Transpl Int. 2012 Apr;25(4):448-54.
29. Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. Lai Q, Avolio AW, Manzia TM, Sorge R, Agnes S, Tisone G, Berloco PB, Rossi M. Clin Transplant. 2012 Mar-Apr;26(2):E125-31.
30. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. Bohne F, Martínez-Llordella M, Lozano JJ, Miquel R, Benítez C, Londoño MC, Manzia TM, Angelico R, Swinkels DW, Tjalsma H, López M, Abraldes JG, Bonaccorsi-Riani E, Jaeckel E, Taubert R, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. J Clin Invest. 2012 Jan 3;122(1):368-82.
31. Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. Anselmo A, Rossi P, De Mayo A, Manzia TM, Iaria G, Toti L, Tisone G. Minerva Chir. 2011 Oct;66(5):495-9.
32. Vitamin D3 modulates T lymphocyte responses in hepatitis C virus-infected liver transplant recipients. Almerighi C, Bergamini A, Lionetti R, Sinistro A, Lenci I, Tariciotti L, Tisone G, Angelico M. Dig Liver Dis. 2012 Jan;44(1):67-73.
33. Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? Lai Q, Avolio AW, Manzia TM, Agnes S, Tisone G, Berloco PB, Rossi M. Int J Biol Markers. 2011 Jul 25;26(3):
34. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group. Am J Transplant. 2011 Dec;11(12):2724-36.
35. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Manzia TM, Angelico R, Toti L, Cillis A, Ciano P, Orlando G, Anselmo A, Angelico M, Tisone G. Transplant Proc. 2011 May;43(4):1181-3.
36. Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. Iaria G, Sforza D, Angelico R, Toti L, de Luca L, Manuelli M, Bellini I, Manzia TM, Anselmo A, Tisone G. Transplant Proc. 2011 May;43(4):1028-9.
37. Liver transplantation for the treatment of nodular regenerative hyperplasia. Manzia TM, Gravante G, Di Paolo D, Orlando G, Toti L, Bellini MI, Ciano P, Angelico M, Tisone G. Dig Liver Dis. 2011 Dec;43(12):929-34.
38. Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. Framarino dei Malatesta M, Corona LE, De Luca L, Rocca B, Manzia TM, Orlando G, Tisone G, Iaria G. Transplantation. 2011 May 15;91(9):e69-71.
39. Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. Manzia TM, Bellini MI, Corona L, Toti L, Fratoni S, Cillis A, Orlando G, Tisone G. Transpl Int. 2011 Aug;24(8):e69-70.
40. Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C. Manzia TM, Angelico R, Toti L, Bellini MI, Sforza D, Palmieri G, Orlando G, Tariciotti L, Angelico M, Tisone G. Transpl Int. 2011 May;24(5):461-8.
41. Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence. Lenci I, Tisone G, Di Paolo D, Marcuccilli F, Tariciotti L, Ciotti M, Svicher V, Perno CF, Angelico M. J Hepatol. 2011 Sep;55(3):587-93.
43. Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F; Liver Match Investigators. Dig Liver Dis. 2011 Feb;43(2):155-64.
44. Management of spermatic cord liposarcoma in renal transplant recipients: case report. Manzia TM, Gravante G, Toti L, Iaria G, Anselmo A, Fratoni S, Angelico R, Sforza D, Manuelli M, Tisone G. Transplant Proc. 2010 May;42(4):1355-7.
45. Conversion to rapamycin immunosuppression for malignancy after kidney transplantation. Manuelli M, De Luca L, Iaria G, Tatangelo P, Sforza D, Perrone L, Bellini MI, Angelico R, Anselmo A, Tisone G. Transplant Proc. 2010 May;42(4):1314-6.
46.Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. Manzia TM, Toti L, Angelico R, Di Cocco P, Orlando G, Tisone G. Transplant Proc. 2010 May;42(4):1237-9.
47.Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results. Manzia TM, Di Paolo D, Sforza D, Toti L, Angelico R, Brega A, Angelico M, Tisone G. Transplant Proc. 2010 May;42(4):1200-3.
48. Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. Iaria G, Pisani F, De Luca L, Sforza D, Manuelli M, Perrone L, Bellini I, Angelico R, Tisone G. Transplant Proc. 2010 May;42(4):1169-70.
49. Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. Orlando G, Di Cocco P, D’Angelo M, Clemente K, Manzia TM, Angelico R, Tisone G, Romagnoli J, Citterio F, Famulari A, Pisani F. Transplant Proc. 2010 May;42(4):1118-9.
50.One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis. Di Paolo D, Lenci I, Cerocchi C, Tariciotti L, Monaco A, Brega A, Lotti L, Tisone G, Angelico M. Transpl Int. 2010 Nov;23(11):1105-12.
51. Characterization of γδ T cell subsets in organ transplantation. Puig-Pey I, Bohne F, Benítez C, López M, Martínez-Llordella M, Oppenheimer F, Lozano JJ, González-Abraldes J, Tisone G, Rimola A, Sánchez-Fueyo A. Transpl Int. 2010 Oct;23(10):1045-55.
52. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, Guenci T, Perno CF, Angelico M. Dig Liver Dis. 2010 Aug;42(8):578-84.
53. Obscure gastrointestinal bleeding as first symptom of eosinophilic jejunitis in a liver transplant recipient: diagnosis and treatment with single balloon enteroscopy. Urgesi R, Riccioni ME, Nista EC, Lionetti R, Tisone G, Familiari P, Ricci R, Pelecca G, Angelico M, Costamagna G. BMJ Case Rep. 2010;2010.
54. Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. Salvadori M, Scolari MP, Bertoni E, Citterio F, Rigotti P, Cossu M, Dal Canton A, Tisone G, Albertazzi A, Pisani F, Gubbiotti G, Piredda G, Busnach G, Sparacino V, Goepel V, Messa P, Berloco P, Montanaro D, Veroux P, Federico S, Bartezaghi M, Corbetta G, Ponticelli C. Transplantation. 2009 Nov 27;88(10):1194-202.
55. Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression. Lionetti R, Tisone G, Palmieri G, Almerighi C, Anselmo A, Tariciotti L, Lenci I, De Luca L, Monaco A, Angelico M. Dig Liver Dis. 2010 Apr;42(4):297-303.
56. Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. Orlando G, Tariciotti L, Manzia TM, Gravante G, Sorge R, Manuelli M, Pisani F, Di Cocco P, Scelzo C, Burke GM, Soker S, Baiocchi L, Lerut J, Angelico M, Tisone G. Transpl Infect Dis. 2010 Feb;12(1):11-5.
57. Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. Toti L, Manzia TM, Romano P, Lenci I, Baiocchi L, Anselmo A, Sforza D, Manuelli M, Tisone G. Transpl Int. 2010 Jan;23(1):114-5.
58. Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. Gentileschi P, Venza M, Benavoli D, Lirosi F, Camperchioli I, D’Eletto M, Lazzaro A, Stolfi VM, Anselmo A, Di Lorenzo N, Tisone G, Gaspari AL. Obes Surg. 2009 Oct;19(10):1460-3.
59. Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. de Liguori Carino N, Manzia TM, Tariciotti L, Berlanda M, Orlando G, Tisone G. Transplant Proc. 2009 May;41(4):1386-9.
60. Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. Pompili M, Pacella CM, Francica G, Angelico M, Tisone G, Craboledda P, Nicolardi E, Rapaccini GL, Gasbarrini G. Eur J Radiol. 2010 Jun;74(3):e6-e11.
61. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group. Lancet Oncol. 2009 Jan;10(1):35-43.
62. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G. Transpl Immunol. 2008 Nov;20(1-2):43-7.
63. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. J Clin Invest. 2008 Aug;118(8):2845-57.
64. Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment. Lenci I, Angelico M, Tisone G, Orlacchio A, Palmieri G, Pinci M, Bombardieri R, Curatolo P. J Hepatol. 2008 Jun;48(6):1026-9.
65. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway. Baiocchi L, Tisone G, Russo MA, Longhi C, Palmieri G, Volpe A, Almerighi C, Telesca C, Carbone M, Toti L, De Leonardis F, Angelico M. Transpl Int. 2008 Aug;21(8):792-800.
66. Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma. Lenci I, Tariciotti L, Baiocchi L, Manzia TM, Toti L, Craboledda P, Callea F, Angelico M, Tisone G. Transpl Int. 2008 Jun;21(6):598-601.
67. Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease. Baiocchi L, Angelico M, Petrolati A, Perrone L, Palmieri G, Battista S, Carbone M, Tariciotti L, Longhi C, Orlando G, Tisone G. Am J Transplant. 2008 Mar;8(3):673-8.
68. Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report. Orlando G, Sabbà C, De Liguori Carino N, Scelzo C, Tariciotti L, Bonanni L, D’Angelo M, Baiocchi L, Lerut J, Tisone G. Liver Int. 2008 Apr;28(4):574-7.